Corium
Yi Xu Phd has extensive experience as a research scientist, specializing in the development and testing of controlled release drug delivery products. They have particular expertise in transdermal products and possess interdisciplinary knowledge in areas such as organic/physical chemistry, surface chemistry, colloid chemistry, engineering, and biology. They have made numerous contributions in defining system components, designing systems, and inventing/improving transdermal delivery products. Additionally, they have held positions as Principal Scientist at Ortho-McNeil Pharmaceutical and as Senior Art Director at Corium. They have also had previous work experience as an Assistant Research Professor, Research Associate, Research Assistant, Instructor, and Teaching and Research Assistant at various institutions.
Yi Xu, PhD, completed a Doctor of Philosophy (PhD) in Biology, General at Penn State University. Prior to that, they also earned a master's degree (MSc) in Biology, General from the same university. Yi Xu obtained their Bachelor's degree in Biology, General from Xiamen University. The exact start and end years for each degree are not provided.
This person is not in any offices
Corium
Corium is a commercial-stage biopharmaceutical company that is leading the development and commercialization of central nervous system (CNS) healthcare therapies that provide clinicians with important treatment options for patients, their families, and their caregivers. Collaborating with some of the world's largest pharmaceutical and consumer product companies, we have a track record and depth of experience in taking products from concept, through development, to manufacturing and final commercialization.